MAM
AMED

Melqart Asset Management’s Amedisys AMED Stock Holding History

Melqart Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-121,479
Closed -$11.3M – 31
2025
Q1 		$11.3M Buy
+121,479
New +$11.2M 1.47% 18
2024
Q4 		– Sell
-275,972
Closed -$26.6M – 48
2024
Q3 		$26.6M Sell
275,972
-75,348
-21% -$7.35M 2.41% 14
2024
Q2 		$32.3M Sell
351,320
-204,123
-37% -$18.9M 2.67% 11
2024
Q1 		$51.2M Sell
555,443
-98,385
-15% -$9.22M 3.19% 10
2023
Q4 		$62.2M Buy
653,828
+303,500
+87% +$28.3M 4.57% 7
2023
Q3 		$32.7M Buy
+350,328
New +$32.4M 2.34% 13

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Melqart Asset Management's AMED Position: Q2 2025 in Review

Melqart Asset Management sold out of Amedisys (AMED) in Q2 2025, closing a stake of 121,479 shares — an estimated $11.3M sold.

Melqart Asset Management first reported a position in AMED in Q3 2023 and held it in 6 quarters. The position peaked at $62.2M in Q4 2023. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Melqart Asset Management reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Melqart Asset Management sold 121,479 Amedisys shares in Q2 2025, an estimated $11.3M.
  • Melqart Asset Management first reported a position in Amedisys in Q3 2023 and held it in 6 quarters.
  • Melqart Asset Management's Amedisys position peaked at $62.2M in Q4 2023.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Melqart Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.